Quantum Pharmaceuticals and its partner organisation, InterBioScreen, participated in this fair in order to present its new joint project, QuantumLead, to venture capitalists
InterBioScreen and Quantum Pharmaceuticals's joint project, QuantumLead, received two awards - for best company and best management - in the Fifth Russian Venture Fair in St Petersburg, the most significant annual event for the Russian venture capital market.
The jury appreciated the outstanding combination of the reputation and experience of InterBioScreen and Quantum Pharmaceuticals's technology.
Quantum Pharmaceuticals and its partner organisation, InterBioScreen, participated in this fair in order to present its new joint project, QuantumLead, to venture capitalists interested in investing in Russia.
This event brings together approximately 100 innovative small and medium sized hi-tech companies for networking with well-known groups such as the European Bank of Reconstruction and Development (EBRD), Baker and McKenzie law firm, Ernst and Young, PricewaterhouseCoopers, and Baring Vostok Capital Partners.
